Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 1999

View Archived Issues

Sugen awarded U.S. patent for transcript imaging technology

Series of Na+/Ca2+ exchange inhibitors for ischemic disorders from Taisho

Potent thrombin inhibitors with heterocyclic structure synthesized at Lilly

ACAT-inhibitory urea derivatives claimed by Mitsubishi for lipid disorders

S-19777: novel ET antagonist of microbial origin

Carbapenems in development at Sankyo

Xanthine oxidase inhibitors for hyperuricemia, gout described by Yoshitomi in patent literature

U.S. patent issued to Millennium covers novel forms of caspase 8

Anika outlines plans for 1999 as regards product pipeline

Proleukin receives orphan drug status for two new indications

New antiobesity target a focus of attention at recent Japanese meeting

New family of gene-regulating enzymes discovered by Signal, Hebrew University

FDA approves OTC status for Elan's nicotine patch

Combinations of K-12 and other anti-HIV compounds tested in vitro for synergy

Phase II trial results published for repaglinide for treatment of type II diabetes

PSC-833 modulates the tumor disposition of vinca alkaloids in vitro and in vivo

More anti-HIV, antimalarial agents available for licensing from NIH

Nonpsychoactive, neuroprotective cannabinoids available for licensing from NIH

CNI-1493 attenuates hemodynamic and cytokine responses to LPS in rats

Favorable preclinical, clinical results continue to encourage development of ABT-378

AxyS initiates phase I clinical trial of APC-2059 for treatment of psoriasis

Fujisawa obtains Japanese marketing rights to Zeneca's atypical antipsychotic quetiapine

Prodrug glucocorticoid NM-135 displays potent antiinflammatory activity, good side effect profile

Ilex and Symphar begin phase I studies of SR-45023A

Interneuron receives milestone payment from Lilly under Prozac agreement

Bristol-Myers Squibb seeks approval for new antibiotic for respiratory and other infections

Remacemide provides neuroprotection during CPB

Photofrin approved in U.K. for palliative treatment of esophageal cancer and late-stage lung cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...